People with chronic fatigue syndrome, also known as ME, to benefit from world-first genomics study.
The government is investing £4.75 million in the world’s largest study of its kind to offer new hope to around 390,000 people living with the condition in the UK
For the first time, scientists will be able to build a high-resolution genetic map of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), paving the way for better diagnostics and future treatments
The funding builds on the government’s earlier investment in the DecodeME study, which created the world’s largest ME/CFS research cohort